The drug firm Torrent Pharmaceuticals announced a 27.04percent rise in consolidated net profit to Rs 310 crore for the quarter ended September mainly on account of robust sales in India and reduction in expenses.
India revenues at Rs 963 crores grew by 7% versus the IPM growth 1% for the quarter as per AIOCD.Torrent pharmaceuticals said in release.
Torrent Pharma is a specialty- focused company with 75% of its revenue in India from chronic and sub-chronic therapies.
